Info

Crosstree Capital Partners provides flexible debt financing solutions to companies on a principal basis. Our capital is "non-captive," meaning we will invest in both clients of the firm as well as companies that do not have an investment banking relationship with Crosstree. Our investments range from $5 million to $30 million per financing, although we will consider smaller or larger investments depending on the circumstances. Unlike most debt investors who work across all industries, Crosstree focuses all investment activity on the life sciences sector in parallel with our investment banking industry coverage, and selectively across the broader healthcare industry. Our narrow focus allows us the following advantages:A better understanding of an industry allows us to more accurately quantify risk and thus provide more cost effective financing to companies;Crosstree can provide highly customized financing solutions, which consider the value in your business often overlooked by traditional financing sources (i.e. intellectual property, licensing agreements, distribution agreements); andFurthermore, given our industry knowledge, our due diligence process is highly efficient allowing for quick decision-making and an expediant closing.Crosstree welcomes new opportunities. Please contact Jeff Ellis for further detail.